Kamal MA - Search Results

1

Single Probiotic versus Multiple Probiotics - A Debate On Current Scenario for Alleviating Health Benefits.

Korada SK, Yarla NS, Mishra V, Daim MA, Sharma B, Gm A, R R, M P, Peluso I, Kamal MA. Korada SK, et al. Among authors: kamal ma. Curr Pharm Des. 2018;24(35):4150-4153. doi: 10.2174/1381612824666181012124136. Curr Pharm Des. 2018. PMID: 30317991 Review.

2

Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Kamal MA, Greig NH. Kamal MA, et al. Curr Pharm Des. 2016;22(28):4337-40. doi: 10.2174/1381612822999160719150757. Curr Pharm Des. 2016. PMID: 27655557 Free PMC article.

3

Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Kamal MA, Greig NH. Kamal MA, et al. Curr Pharm Des. 2017;23(11):1571-1574. doi: 10.2174/1381612823999170201155228. Curr Pharm Des. 2017. PMID: 28701141 Free PMC article. No abstract available.

4

Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities.

Rayavarapu S, Yarla NS, Kadiri SK, Bishayee A, Vidavalur S, Tadikonda R, Basha M, Pidugu VR, Dowluru KSVGK, Lakappa DB, Kamal MA, Md Ashraf G, Tarasov VV, Chubarev VN, Klochkov SG, Barreto GE, Bachurin SO, Aliev G. Rayavarapu S, et al. Among authors: kamal ma. Sci Rep. 2017 Aug 16;7(1):8309. doi: 10.1038/s41598-017-05832-w. Sci Rep. 2017. PMID: 28814788 Free PMC article.

5

Preventive and Therapeutic Potentials of Anthocyanins in Diabetes and Associated Complications.

Putta S, Yarla NS, Kumar K E, Lakkappa DB, Kamal MA, Scotti L, Scotti MT, Ashraf GM, Rao BSB, D SK, Reddy GV, Tarasov VV, Imandi SB, Aliev G. Putta S, et al. Among authors: kamal ma. Curr Med Chem. 2018;25(39):5347-5371. doi: 10.2174/0929867325666171206101945. Curr Med Chem. 2018. PMID: 29210634 Review.

6

Frontier View on Nanotechnological Strategies for Neuro-therapy.

Azhar A, Ashraf GM, Zia Q, Ansari SA, Perveen A, Hafeez A, Saeed M, Kamal MA, Alexiou A, Ganash M, Yarla NS, Baeesa SS, Alfiky MM, Bajouh OS. Azhar A, et al. Among authors: kamal ma. Curr Drug Metab. 2018;19(7):596-604. doi: 10.2174/1389200219666180305144143. Curr Drug Metab. 2018. PMID: 29512448 Review.

7

Influence of Hormones on Sjögren's Syndrome.

Yang L, Wei W, He X, Xie Y, Kamal MA, Li J. Yang L, et al. Among authors: kamal ma. Curr Pharm Des. 2018;24(35):4167-4176. doi: 10.2174/1381612824666181010153536. Curr Pharm Des. 2018. PMID: 30724137 Review.

8

What is Blockchain Technology and its Significance in the Current Healthcare System? A Brief Insight.

Ahmad SS, Khan S, Kamal MA. Ahmad SS, et al. Among authors: kamal ma. Curr Pharm Des. 2019;25(12):1402-1408. doi: 10.2174/1381612825666190620150302. Curr Pharm Des. 2019. PMID: 31258067 Review.

9

Can Wogonin be Used in Controlling Diabetic Cardiomyopathy?

Khan S, Kamal MA. Khan S, et al. Among authors: kamal ma. Curr Pharm Des. 2019;25(19):2171-2177. doi: 10.2174/1381612825666190708173108. Curr Pharm Des. 2019. PMID: 31298148 Review.

10

Wogonin Alleviates Hyperglycemia Through Increased Glucose Entry into Cells Via AKT/GLUT4 Pathway.

Khan S, Kamal MA. Khan S, et al. Among authors: kamal ma. Curr Pharm Des. 2019;25(23):2602-2606. doi: 10.2174/1381612825666190722115410. Curr Pharm Des. 2019. PMID: 31333118 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

768 results

Search Page